Results 11 to 20 of about 200,643 (293)

Inflammatory vaginitis in women on long-term rituximab treatment for autoimmune disorders

open access: yesBMC Women's Health, 2021
Background Consequences of long-term B cell depletion with rituximab are not well understood. We describe inflammatory vaginitis as a potential side effect of long-term rituximab treatment, distinct from previously described vulvovaginal pyoderma ...
Laura Yockey   +8 more
doaj   +1 more source

Diagnostic delays in vasculitis and factors associated with time to diagnosis

open access: yesOrphanet Journal of Rare Diseases, 2021
Background Patients with vasculitis, a set of rare diseases, encounter delays in obtaining an accurate diagnosis which can lead to substantial morbidity and increased mortality.
Antoine G. Sreih   +9 more
doaj   +1 more source

Reuma.pt/vasculitis – the Portuguese vasculitis registry [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2020
AbstractBackgroundThe vasculitides are a group of rare diseases with different manifestations and outcomes. New therapeutic options have led to the need for long-term registries. The Rheumatic Diseases Portuguese Register, Reuma.pt, is a web-based electronic clinical record, created in 2008, which currently includes specific modules for 12 diseases and 
Ponte, Cristina   +33 more
openaire   +5 more sources

A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol

open access: yesTrials, 2023
Background Sequential B cell-targeted immunotherapy with BAFF antagonism (belimumab) and B cell depletion (rituximab) may enhance B cell targeting in ANCA-associated vasculitis (AAV) through several mechanisms.
Mark E. McClure   +13 more
doaj   +1 more source

Clinical-evolutional particularities of the cryoglobulinemic vasculitis in the case of a patient diagnosed with hepatitis C virus in the predialitic phase [PDF]

open access: yes, 2018
Hepatitis C virus (HCV) represents a fundamental issue for public health, with long term evolution and the gradual appearance of several complications and associated pathologies.
Boldeanu, Lidia   +12 more
core   +6 more sources

A sore red eye with systemic involvement [PDF]

open access: yes, 2010
The study of happiness has long been a playground for philosophical speculation. By lack of empirical measures of happiness, it was not possible to check propositions about the matter.
Lightman, SL   +3 more
core   +2 more sources

Introduction to the PANLAR Guidelines: Giant Cell Arteritis

open access: yesGlobal Rheumatology, 2022
Introduction to the PANLAR Guidelines: Giant Cell Arteritis Dr. Sebastián Unizony describes how the process of construction and consolidation of this document by a team of experts was.
Sebastian Unizony
doaj   +1 more source

Immune-Complex Allergic Vasculitis in Association with the Immune-Complex Allergic Vasculitis in Association with the Development of Transverse Myelitis: A Case Report [PDF]

open access: yes, 1996
A severe vasculitis, probably therapy related, in a sixty-four-year-old man being treated for possible subacute bacterial endocarditis, was associated with the development of transverse myelitis.
Günter Pilz   +5 more
core   +1 more source

Patient involvement in medical research: what patients and physicians learn from each other

open access: yesOrphanet Journal of Rare Diseases, 2019
Background There is increasing interest in actively involving patients in the process of medical research to help ensure research is relevant and important to both researchers and people affected by the disease under study.
Kalen Young   +11 more
doaj   +1 more source

Optimal management of Cogan’s syndrome: a multidisciplinary approach [PDF]

open access: yes, 2017
Cogan's syndrome (CS) is a rare disorder characterized by nonsyphilitic interstitial keratitis (IK) and audio-vestibular symptoms. CS affects mainly young Caucasian adults, mostly during their first three decades of age, and may develop into typical and ...
D'Aguanno, Vittorio   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy